BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 37345064)

  • 1. Salvage Radical Prostatectomy after Primary Focal Ablative Therapy: A Systematic Review and Meta-Analysis.
    Blank F; Meyer M; Wang H; Abbas H; Tayebi S; Hsu WW; Sidana A
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer control and functional outcomes of salvage radical prostatectomy for radiation-recurrent prostate cancer: a systematic review of the literature.
    Chade DC; Eastham J; Graefen M; Hu JC; Karnes RJ; Klotz L; Montorsi F; van Poppel H; Scardino PT; Shariat SF
    Eur Urol; 2012 May; 61(5):961-71. PubMed ID: 22280856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topography of Prostate Cancer Recurrence: A Single-centre Analysis of Salvage Radical Prostatectomy Specimens and Implications for Focal Salvage Treatments.
    Marra G; Calleris G; Massari E; Vissio E; Molinaro L; Cassoni P; D'Agate D; Oderda M; Valerio M; Raskin Y; Joniau S; Papotti M; Gontero P
    Eur Urol Open Sci; 2023 Jan; 47():110-118. PubMed ID: 36601045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the Toxicity of Salvage Prostatectomy Related to the Primary Prostate Cancer Therapy Received?
    Ribeiro L; Stonier T; Stroman L; Tourinho-Barbosa R; Alghazo O; Winkler M; Dasgupta P; Popert R; Cathelineau X; Sanchez-Salas R; Murphy DG; Emberton M; Cathcart P
    J Urol; 2021 Mar; 205(3):791-799. PubMed ID: 33021441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer.
    van Riel LAMJG; Geboers B; Kabaktepe E; Blazevski A; Reesink DJ; Stijns P; Stricker PD; Casanova J; Dominguez-Escrig JL; de Reijke TM; Scheltema MJ; Oddens JR
    BJU Int; 2022 Nov; 130(5):611-618. PubMed ID: 35474600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy.
    Rodler S; Danninger D; Eismann L; Kazmierczak PM; Jokisch F; Li M; Becker A; Kretschmer A; Stief C; Westhofen T
    World J Urol; 2024 Apr; 42(1):242. PubMed ID: 38635030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salvage radical prostatectomy for recurrent prostate cancer: verification of European Association of Urology guideline criteria.
    Mandel P; Steuber T; Ahyai S; Kriegmair M; Schiffmann J; Boehm K; Heinzer H; Michl U; Schlomm T; Haese A; Huland H; Graefen M; Tilki D
    BJU Int; 2016 Jan; 117(1):55-61. PubMed ID: 25711672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Oncologic and Toxicity Outcomes of Salvage Radical Prostatectomy Versus Nonsurgical Therapies for Radiorecurrent Prostate Cancer: A Meta-Regression Analysis.
    Philippou Y; Parker RA; Volanis D; Gnanapragasam VJ
    Eur Urol Focus; 2016 Jun; 2(2):158-171. PubMed ID: 28723532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage Versus Primary Robot-assisted Radical Prostatectomy: A Propensity-matched Comparative Effectiveness Study from a High-volume Tertiary Centre.
    Nathan A; Fricker M; De Groote R; Arora A; Phuah Y; Flora K; Patel S; Kasivisvanathan V; Sridhar A; Shaw G; Kelly J; Briggs T; Rajan P; Sooriakumaran P; Nathan S
    Eur Urol Open Sci; 2021 May; 27():43-52. PubMed ID: 33997823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent Gleason Score 6 Prostate Cancer After Radiotherapy or Ablation: Should We Observe Them All? Results from a Large Multicenter Salvage Radical Prostatectomy Consortium.
    Marra G; Calleris G; Conte F; Benfant N; Rajwa P; Ahmed M; Abreu A; Cacciamani G; Smith JA; Joniau S; Rodriguez-Sanchez L; Sanchez-Salas R; Cathcart P; Gill I; Karnes RJ; Tilki D; Shariat SF; Touijer K; Gontero P
    Eur Urol Focus; 2023 Sep; ():. PubMed ID: 37704503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage radical prostatectomy following focal therapy: functional and oncological outcomes.
    Herrera-Caceres JO; Nason GJ; Salgado-Sanmamed N; Goldberg H; Woon DTS; Chandrasekar T; Ajib K; Tan GH; Alhunaidi O; van der Kwast T; Finelli A; Zlotta AR; Hamilton RJ; Berlin A; Perlis N; Fleshner NE
    BJU Int; 2020 Apr; 125(4):525-530. PubMed ID: 31863617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage Local Treatments After Focal Therapy for Prostate Cancer.
    Marra G; Valerio M; Emberton M; Heidenreich A; Crook JM; Bossi A; Pisters LL
    Eur Urol Oncol; 2019 Sep; 2(5):526-538. PubMed ID: 31412013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage Radical Prostatectomy for Recurrent Prostate Cancer: A Systematic Review (French ccAFU).
    Saouli A; Ruffion A; Dariane C; Barret E; Fiard G; Hankard GF; Créhange G; Roubaud G; Beauval JB; Brureau L; Renard-Penna R; Gauthé M; Baboudjian M; Ploussard G; Rouprêt M
    Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications, oncological and functional outcomes of salvage treatment options following focal therapy for localized prostate cancer: a systematic review and a comprehensive narrative review.
    Marra G; Gontero P; Walz JC; Sivaraman A; Tourinho-Barbosa R; Cathelineau X; Sanchez-Salas R
    World J Urol; 2019 Aug; 37(8):1517-1534. PubMed ID: 30710157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage Radical Prostatectomy for Recurrent Prostate Cancer After Primary Nonsurgical Treatment: An Updated Systematic Review.
    Marra G; Marquis A; Yanagisawa T; Shariat SF; Touijer K; Gontero P
    Eur Urol Focus; 2023 Mar; 9(2):251-257. PubMed ID: 36822924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage radical prostatectomy for radiation-recurrent prostate cancer: a multi-institutional collaboration.
    Chade DC; Shariat SF; Cronin AM; Savage CJ; Karnes RJ; Blute ML; Briganti A; Montorsi F; van der Poel HG; Van Poppel H; Joniau S; Godoy G; Hurtado-Coll A; Gleave ME; Dall'Oglio M; Srougi M; Scardino PT; Eastham JA
    Eur Urol; 2011 Aug; 60(2):205-10. PubMed ID: 21420229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness Analyses of Salvage Prostatectomy and Salvage Radiotherapy Outcomes Following Focal or Whole-Gland Ablative Therapy (High-Intensity Focused Ultrasound, Cryotherapy or Electroporation) for Localised Prostate Cancer.
    Nathan A; Ng A; Mitra A; Sooriakumaran P; Davda R; Patel S; Fricker M; Kelly J; Shaw G; Rajan P; Sridhar A; Nathan S; Payne H
    Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e69-e78. PubMed ID: 34740477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after salvage radical prostatectomy and first-line radiation therapy or HIFU for recurrent localized prostate cancer: results from a multicenter study.
    Clery R; Grande P; Seisen T; Gobert A; Duquesne I; Villers A; Olivier J; Bernhard JC; Robert G; Beauval JB; Prudhomme T; Bruyère F; Lainé-Caroff P; Waltregny D; Guillonneau B; Panarello D; Ruffion A; De Bayser H; de La Taille A; Roupret M
    World J Urol; 2019 Aug; 37(8):1491-1498. PubMed ID: 30790014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage Radical Prostatectomy for Radio-Recurrent Prostate Cancer: An Updated Systematic Review of Oncologic, Histopathologic and Functional Outcomes and Predictors of Good Response.
    Grubmüller B; Jahrreiss V; Brönimann S; Quhal F; Mori K; Heidenreich A; Briganti A; Tilki D; Shariat SF
    Curr Oncol; 2021 Jul; 28(4):2881-2892. PubMed ID: 34436018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peri-operative, functional and early oncologic outcomes of salvage robotic-assisted radical prostatectomy after high-intensity focused ultrasound partial ablation.
    Thompson JE; Sridhar AN; Shaw G; Rajan P; Mohammed A; Briggs TP; Nathan S; Kelly JD; Sooriakumaran P
    BMC Urol; 2020 Jul; 20(1):81. PubMed ID: 32611411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.